AstraZeneca ups profit outlook on strong cancer drugs demand

AstraZeneca to pay $425 million to settle Nexium, Prilosec litigation in US

AstraZeneca refused to pay full bonus to US remote worker, lawsuit claims

AstraZeneca's Tagrisso-chemo combo results raise bar for J&J cancer drug-analysts

AstraZeneca files litigation to challenge Inflation Reduction Act

AstraZeneca to buy Pfizer's rare disease gene therapy portfolio for up to $1 billion

AstraZeneca planning China business spin off -FT

AstraZeneca drug combo gets US nod to treat a type of prostate cancer